Baupost Group Discloses 35 Percent Stake In Idenix Pharmaceuticals

Baupost Group, the hedge fund founded and managed by Seth Klarman, disclosed ownership of 53,331,109 shares (a 35.38% stake) in Idenix Pharmaceuticals Inc (NASDAQ:IDIX) based on its 13D filing with the Securities and Exchange Commission (SEC), and as first reported by ValueWalk. Baupost 35% $IDIX http://t.co/ezUXizp5iZ — ValueWalk.com (@valuewalk) February 4, 2014   The hedge fund increased its stock holdings in Idenix Pharmaceuticals Inc (NASDAQ:IDIX) by 44.49% from its previous position of 36,910,869 shares at the end of December 2013. Baupost Group receives observer rights Based on its regulatory filing, the board of directors and the committees of the company…